{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:53:02Z","timestamp":1787064782298,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>MicroRNAs are key biomarkers for human diseases; however, experimentally identifying miRNA-disease associations was costly and inefficient. To improve the robustness and interpretability of computational models, we developed a multi-order adaptive graph-based miRNA-disease association model (MAGMDA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MAGMDA introduced an adaptive moment-order selection mechanism and a dynamic threshold network, which replaced the fixed moment orders and manually defined thresholds commonly used in traditional high-order statistical modeling with learnable components. By integrating numerically stable high-order moment computation with cross-order attention aggregation, MAGMDA enhanced model robustness and interpretability while maintaining computational efficiency. Five-fold cross-validation on the HMDD v2.0 dataset showed that MAGMDA achieved an AUC of 93.58% and an AUPR of 93.48%. Across multiple evaluation metrics, MAGMDA outperformed representative existing methods, exhibiting particularly consistent advantages on ranking-related metrics such as the area under the receiver operating characteristic curve (AUC) and the area under the precision\u2013recall curve (AUPR), while maintaining smaller performance variations across different cross-validation folds, indicating stable predictive ability under different data partitions. Mechanistic diagnostic analysis further verified the stable utilization of the adaptive modules across different training folds. To demonstrate biological utility, we applied MAGMDA to hepatocellular carcinoma research. Based on the model predictions and analysis of the TCGA-LIHC cohort, we constructed a seven-gene prognostic signature, which was successfully validated in independent datasets and showed strong prognostic stratification ability, highlighting its potential for clinical translation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      MAGMDA effectively improved miRNA-disease association prediction through an adaptive multi-order moment modeling framework and, supported by systematic biological validation, provided a powerful tool for translational research from computational discovery to clinical application. The MAGMDA framework and data resources are publicly available at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/github.com\/zhangclbio\/MAGMDA\" ext-link-type=\"uri\">https:\/\/github.com\/zhangclbio\/MAGMDA<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12859-026-06433-z","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:26:15Z","timestamp":1774679175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MAGMDA: a multi-order adaptive graph-based miRNA-disease association prediction model"],"prefix":"10.1186","volume":"27","author":[{"given":"Xiujuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"R1","key":"6433_CR1","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1093\/hmg\/ddm056","volume":"16","author":"C Blenkiron","year":"2007","unstructured":"Blenkiron C, Miska EA. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet. 2007;16(R1):R106\u201313.","journal-title":"Hum Mol Genet"},{"key":"6433_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cca.2021.01.008","volume":"516","author":"Y Wu","year":"2021","unstructured":"Wu Y, et al. Circulating microRNAs: biomarkers of disease. Clin Chim Acta. 2021;516:46\u201354.","journal-title":"Clin Chim Acta"},{"key":"6433_CR3","doi-asserted-by":"publisher","first-page":"e12147","DOI":"10.7717\/peerj.12147","volume":"9","author":"M Liu","year":"2021","unstructured":"Liu M, et al. Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis. PeerJ. 2021;9:e12147.","journal-title":"PeerJ"},{"issue":"4","key":"6433_CR4","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.3390\/ijms24043157","volume":"24","author":"MA Eldosoky","year":"2023","unstructured":"Eldosoky MA, et al. Diagnostic significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p panel and ratios in hepatocellular carcinoma on top of liver cirrhosis in HCV-infected patients. Int J Mol Sci. 2023;24(4):3157.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"6433_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00432-010-0918-4","volume":"137","author":"W Gao","year":"2011","unstructured":"Gao W, et al. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol. 2011;137(4):557\u201366.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"6433_CR6","doi-asserted-by":"publisher","first-page":"38262","DOI":"10.1038\/srep38262","volume":"6","author":"E Raitoharju","year":"2016","unstructured":"Raitoharju E, et al. Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism: the Young Finns Study. Sci Rep. 2016;6(1):38262.","journal-title":"Sci Rep"},{"key":"6433_CR7","doi-asserted-by":"publisher","first-page":"p1584734","DOI":"10.3389\/fphar.2025.1584734","volume":"16","author":"M Cherubin","year":"2025","unstructured":"Cherubin M, et al. Bridging the gaps in detection of structural cardiotoxicity in stem cellderived cardiomyocytes: promise of miR-133, miR-184 and miR-208-3p. Front Pharmacol. 2025;16:p1584734.","journal-title":"Front Pharmacol"},{"key":"6433_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.diabres.2018.03.024","volume":"140","author":"X Deng","year":"2018","unstructured":"Deng X, et al. B-RCA revealed circulating miR-33a\/b associates with serum cholesterol in type 2 diabetes patients at high risk of ASCVD. Diabetes Res Clin Pract. 2018;140:191\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"6433_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12263-021-00689-1","volume":"16","author":"G Iacomino","year":"2021","unstructured":"Iacomino G, et al. The association of circulating miR-191 and miR-375 expression levels with markers of insulin resistance in overweight children: an exploratory analysis of the I. Family Study. Genes Nutr. 2021;16(1):10.","journal-title":"Genes Nut"},{"issue":"3","key":"6433_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10067-018-4380-z","volume":"38","author":"A Singh","year":"2019","unstructured":"Singh A, Patro PS, Aggarwal A. MicroRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38(3):877\u201384.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"6433_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12031-013-0190-6","volume":"52","author":"X Gu","year":"2014","unstructured":"Gu X, et al. miR-124 represses ROCK1 expression to promote neurite elongation through activation of the PI3K\/Akt signal pathway. J Mol Neurosci. 2014;52(1):156\u201365.","journal-title":"J Mol Neurosci"},{"issue":"3","key":"6433_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1261\/rna.7240905","volume":"11","author":"S Baskerville","year":"2005","unstructured":"Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA. 2005;11(3):241\u20137.","journal-title":"RNA"},{"issue":"5520","key":"6433_CR13","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1126\/science.1060786","volume":"292","author":"WK Johnston","year":"2001","unstructured":"Johnston WK, et al. RNA-catalyzed RNA polymerization: accurate and general RNA-templated primer extension. Science. 2001;292(5520):1319\u201325.","journal-title":"Science"},{"issue":"4","key":"6433_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.molcel.2015.05.004","volume":"58","author":"JA Reuter","year":"2015","unstructured":"Reuter JA, Spacek DV, Snyder MP. High-throughput sequencing technologies. Mol Cell. 2015;58(4):586\u201397.","journal-title":"Mol Cell"},{"issue":"10","key":"6433_CR15","doi-asserted-by":"publisher","first-page":"e3420","DOI":"10.1371\/journal.pone.0003420","volume":"3","author":"M Lu","year":"2008","unstructured":"Lu M, et al. An analysis of human microRNA and disease associations. PLoS ONE. 2008;3(10):e3420.","journal-title":"PLoS ONE"},{"key":"6433_CR16","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fgene.2019.01234","volume":"10","author":"J Xu","year":"2019","unstructured":"Xu J, et al. Identifying potential miRNAs\u2013disease associations with probability matrix factorization. Front Genet. 2019;10:1234.","journal-title":"Front Genet"},{"issue":"3","key":"6433_CR17","doi-asserted-by":"publisher","first-page":"bbaa186","DOI":"10.1093\/bib\/bbaa186","volume":"22","author":"X Chen","year":"2021","unstructured":"Chen X, et al. Deep-belief network for predicting potential miRNA-disease associations. Brief Bioinform. 2021;22(3):bbaa186.","journal-title":"Brief Bioinform"},{"issue":"1","key":"6433_CR18","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1038\/srep05501","volume":"4","author":"X Chen","year":"2014","unstructured":"Chen X, Yan G-Y. Semi-supervised learning for potential human microRNA-disease associations inference. Sci Rep. 2014;4(1):5501.","journal-title":"Sci Rep"},{"issue":"4","key":"6433_CR19","doi-asserted-by":"publisher","first-page":"bbaa243","DOI":"10.1093\/bib\/bbaa243","volume":"22","author":"Z Yu","year":"2021","unstructured":"Yu Z, et al. Predicting drug\u2013disease associations through layer attention graph convolutional network. Brief Bioinform. 2021;22(4):bbaa243.","journal-title":"Brief Bioinform"},{"issue":"6","key":"6433_CR20","doi-asserted-by":"publisher","first-page":"bbab174","DOI":"10.1093\/bib\/bbab174","volume":"22","author":"X Tang","year":"2021","unstructured":"Tang X, et al. Multi-view multichannel attention graph convolutional network for miRNA\u2013disease association prediction. Brief Bioinform. 2021;22(6):bbab174.","journal-title":"Brief Bioinform"},{"key":"6433_CR21","doi-asserted-by":"crossref","unstructured":"Du L et al. Gbk-gnn: gated bi-kernel graph neural networks for modeling both homophily and heterophily. In: Proceedings of the ACM web conference 2022. 2022.","DOI":"10.1145\/3485447.3512201"},{"issue":"D1","key":"6433_CR22","doi-asserted-by":"publisher","first-page":"D1070","DOI":"10.1093\/nar\/gkt1023","volume":"42","author":"Y Li","year":"2014","unstructured":"Li Y, et al. HMDD v2. 0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Res. 2014;42(D1):D1070\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"6433_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"1","key":"6433_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"7291","key":"6433_CR25","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature08987","volume":"464","author":"ICG Consortium","year":"2010","unstructured":"Consortium ICG. International network of cancer genome projects. Nature. 2010;464(7291):993.","journal-title":"Nature"},{"issue":"8","key":"6433_CR26","doi-asserted-by":"publisher","first-page":"e70204","DOI":"10.1371\/journal.pone.0070204","volume":"8","author":"P Xuan","year":"2013","unstructured":"Xuan P, et al. Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors. PLoS ONE. 2013;8(8):e70204.","journal-title":"PLoS ONE"},{"issue":"21","key":"6433_CR27","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/bioinformatics\/btr500","volume":"27","author":"T Van Laarhoven","year":"2011","unstructured":"Van Laarhoven T, Nabuurs SB, Marchiori E. Gaussian interaction profile kernels for predicting drug\u2013target interaction. Bioinformatics. 2011;27(21):3036\u201343.","journal-title":"Bioinformatics"},{"key":"6433_CR28","doi-asserted-by":"crossref","unstructured":"Grover A, Leskovec J. node2vec: scalable feature learning for networks. In: Proceedings of the 22nd ACM SIGKDD international conference on Knowledge discovery and data mining. 2016.","DOI":"10.1145\/2939672.2939754"},{"key":"6433_CR29","unstructured":"Jang E, Gu S, Poole B. Categorical reparameterization with gumbel-softmax. arXiv preprint arXiv:1611.01144, 2016."},{"key":"6433_CR30","unstructured":"Veli\u010dkovi\u0107 P et al. Graph attention networks. arXiv preprint arXiv:1710.10903, 2017."},{"key":"6433_CR31","unstructured":"Targ S, Almeida D, Lyman K. Resnet in resnet: generalizing residual architectures. arXiv preprint arXiv:1603.08029, 2016."},{"key":"6433_CR32","doi-asserted-by":"crossref","unstructured":"Chen D et al. Measuring and relieving the over-smoothing problem for graph neural networks from the topological view. In: Proceedings of the AAAI conference on artificial intelligence. 2020.","DOI":"10.1609\/aaai.v34i04.5747"},{"issue":"D1","key":"6433_CR33","doi-asserted-by":"publisher","first-page":"D812","DOI":"10.1093\/nar\/gkw1079","volume":"45","author":"Z Yang","year":"2017","unstructured":"Yang Z, et al. dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers. Nucleic Acids Res. 2017;45(D1):D812\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"6433_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"D1","key":"6433_CR35","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"6433_CR36","first-page":"D148","volume":"48","author":"H-Y Huang","year":"2020","unstructured":"Huang H-Y, et al. miRTarBase 2020: updates to the experimentally validated microRNA\u2013target interaction database. Nucleic Acids Res. 2020;48(D1):D148\u201354.","journal-title":"Nucleic Acids Res"},{"key":"6433_CR37","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, et al. Predicting effective microRNA target sites in mammalian mRNAs. elife. 2015;4:e05005.","journal-title":"elife"},{"issue":"1","key":"6433_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"W1","key":"6433_CR39","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6433_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"6433_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"6433_CR42","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"6433_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J Roy Stat Soc: Ser B (Methodol). 1972;34(2):187\u2013202.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"1","key":"6433_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. J Royal Stat Soc Ser B: Stat Methodol. 1996;58(1):267\u201388.","journal-title":"J Royal Stat Soc Ser B: Stat Methodol"},{"issue":"282","key":"6433_CR45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457\u201381.","journal-title":"J Am Stat Assoc"},{"issue":"30","key":"6433_CR46","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time\u2010dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381\u201397.","journal-title":"Stat Med"},{"issue":"12","key":"6433_CR47","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"3","key":"6433_CR48","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163\u201370.","journal-title":"Cancer Chemother Rep"},{"issue":"43","key":"6433_CR49","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"6433_CR50","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"6","key":"6433_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2307\/3001968","volume":"1","author":"F Wilcoxon","year":"1945","unstructured":"Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bull. 1945;1(6):80\u20133.","journal-title":"Biometrics Bull"},{"key":"6433_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.knosys.2019.03.023","volume":"175","author":"Q Xiao","year":"2019","unstructured":"Xiao Q, et al. Multi-view manifold regularized learning-based method for prioritizing candidate disease miRNAs. Knowl Based Syst. 2019;175:118\u201329.","journal-title":"Knowl Based Syst"},{"issue":"2","key":"6433_CR53","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1109\/TCBB.2022.3170843","volume":"20","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. Predicting miRNA-disease associations via node-level attention graph auto-encoder. IEEE\/ACM Trans Comput Biol Bioinf. 2022;20(2):1308\u201318.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinf"},{"issue":"22","key":"6433_CR54","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1093\/bioinformatics\/btz297","volume":"35","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Chen X, Yin J. Adaptive boosting-based computational model for predicting potential miRNA-disease associations. Bioinformatics. 2019;35(22):4730\u20138.","journal-title":"Bioinformatics"},{"issue":"5","key":"6433_CR55","doi-asserted-by":"publisher","first-page":"bbae412","DOI":"10.1093\/bib\/bbae412","volume":"25","author":"Z Li","year":"2024","unstructured":"Li Z, et al. HHOMR: a hybrid high-order moment residual model for miRNA-disease association prediction. Brief Bioinform. 2024;25(5):bbae412.","journal-title":"Brief Bioinform"},{"issue":"9","key":"6433_CR56","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1373\/clinchem.2015.241190","volume":"61","author":"Y He","year":"2015","unstructured":"He Y, et al. Current state of circulating microRNAs as cancer biomarkers. Clin Chem. 2015;61(9):1138\u201355.","journal-title":"Clin Chem"},{"issue":"2","key":"6433_CR57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.121.14536","volume":"78","author":"J Liu","year":"2021","unstructured":"Liu J, et al. miR-204: molecular regulation and role in cardiovascular and renal diseases. Hypertension. 2021;78(2):270\u201381.","journal-title":"Hypertension"},{"issue":"6833","key":"6433_CR58","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35075138","volume":"411","author":"H Jeong","year":"2001","unstructured":"Jeong H, et al. Lethality and centrality in protein networks. Nature. 2001;411(6833):41\u20132.","journal-title":"Nature"},{"issue":"2","key":"6433_CR59","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.surg.2023.04.030","volume":"174","author":"K Chida","year":"2023","unstructured":"Chida K, et al. E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma. Surgery. 2023;174(2):307\u201314.","journal-title":"Surgery"},{"issue":"2","key":"6433_CR60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.14740\/wjon1751","volume":"15","author":"V Ramos-Santillan","year":"2024","unstructured":"Ramos-Santillan V, et al. High Ki67 gene expression is associated with aggressive phenotype in hepatocellular carcinoma. World J Oncol. 2024;15(2):257.","journal-title":"World J Oncol"},{"issue":"50","key":"6433_CR61","doi-asserted-by":"publisher","first-page":"E11874","DOI":"10.1073\/pnas.1807305115","volume":"115","author":"G Bidkhori","year":"2018","unstructured":"Bidkhori G, et al. Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes. Proc Natl Acad Sci. 2018;115(50):E11874\u2013E11883.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"6433_CR62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"issue":"8","key":"6433_CR63","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"6433_CR64","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-026-06433-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-026-06433-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-026-06433-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:02:28Z","timestamp":1781643748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12859-026-06433-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6433"],"URL":"https:\/\/doi.org\/10.1186\/s12859-026-06433-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8697093\/v1","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}